267 related articles for article (PubMed ID: 29146181)
1. Proximity labeling of cis-ligands of CD22/Siglec-2 reveals stepwise α2,6 sialic acid-dependent and -independent interactions.
Alborzian Deh Sheikh A; Akatsu C; Imamura A; Abdu-Allah HHM; Takematsu H; Ando H; Ishida H; Tsubata T
Biochem Biophys Res Commun; 2018 Jan; 495(1):854-859. PubMed ID: 29146181
[TBL] [Abstract][Full Text] [Related]
2. Identification of Siglec Ligands Using a Proximity Labeling Method.
Chang L; Chen YJ; Fan CY; Tang CJ; Chen YH; Low PY; Ventura A; Lin CC; Chen YJ; Angata T
J Proteome Res; 2017 Oct; 16(10):3929-3941. PubMed ID: 28899088
[TBL] [Abstract][Full Text] [Related]
3. Identification of Siglec Cis-Ligands by Proximity Labeling.
Alborzian Deh Sheikh A; Akatsu C; Tsubata T
Methods Mol Biol; 2020; 2132():75-83. PubMed ID: 32306316
[TBL] [Abstract][Full Text] [Related]
4. Siglec cis-ligands and their roles in the immune system.
Tsubata T
Glycobiology; 2023 Aug; 33(7):532-544. PubMed ID: 37154567
[TBL] [Abstract][Full Text] [Related]
5. CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
Nitschke L
Glycobiology; 2014 Sep; 24(9):807-17. PubMed ID: 25002414
[TBL] [Abstract][Full Text] [Related]
6. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.
Matsubara N; Imamura A; Yonemizu T; Akatsu C; Yang H; Ueki A; Watanabe N; Abdu-Allah H; Numoto N; Takematsu H; Kitazume S; Tedder TF; Marth JD; Ito N; Ando H; Ishida H; Kiso M; Tsubata T
Front Immunol; 2018; 9():820. PubMed ID: 29725338
[TBL] [Abstract][Full Text] [Related]
7. Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking.
Han S; Collins BE; Bengtson P; Paulson JC
Nat Chem Biol; 2005 Jul; 1(2):93-7. PubMed ID: 16408005
[TBL] [Abstract][Full Text] [Related]
8. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes.
Razi N; Varki A
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7469-74. PubMed ID: 9636173
[TBL] [Abstract][Full Text] [Related]
9. Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact.
Collins BE; Blixt O; DeSieno AR; Bovin N; Marth JD; Paulson JC
Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6104-9. PubMed ID: 15079087
[TBL] [Abstract][Full Text] [Related]
10. Sialic Acid Ligand Binding of CD22 and Siglec-G Determines Distinct B Cell Functions but Is Dispensable for B Cell Tolerance Induction.
Özgör L; Meyer SJ; Korn M; Terörde K; Nitschke L
J Immunol; 2018 Oct; 201(7):2107-2116. PubMed ID: 30143587
[TBL] [Abstract][Full Text] [Related]
11. Sialic acids and autoimmune disease.
Mahajan VS; Pillai S
Immunol Rev; 2016 Jan; 269(1):145-61. PubMed ID: 26683151
[TBL] [Abstract][Full Text] [Related]
12. Unmasking of CD22 Co-receptor on Germinal Center B-cells Occurs by Alternative Mechanisms in Mouse and Man.
Macauley MS; Kawasaki N; Peng W; Wang SH; He Y; Arlian BM; McBride R; Kannagi R; Khoo KH; Paulson JC
J Biol Chem; 2015 Dec; 290(50):30066-77. PubMed ID: 26507663
[TBL] [Abstract][Full Text] [Related]
13. High-affinity ligand probes of CD22 overcome the threshold set by cis ligands to allow for binding, endocytosis, and killing of B cells.
Collins BE; Blixt O; Han S; Duong B; Li H; Nathan JK; Bovin N; Paulson JC
J Immunol; 2006 Sep; 177(5):2994-3003. PubMed ID: 16920935
[TBL] [Abstract][Full Text] [Related]
14. Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.
Spiller F; Nycholat CM; Kikuchi C; Paulson JC; Macauley MS
J Immunol; 2018 Feb; 200(3):949-956. PubMed ID: 29288201
[TBL] [Abstract][Full Text] [Related]
15. In situ trans ligands of CD22 identified by glycan-protein photocross-linking-enabled proteomics.
Ramya TN; Weerapana E; Liao L; Zeng Y; Tateno H; Liao L; Yates JR; Cravatt BF; Paulson JC
Mol Cell Proteomics; 2010 Jun; 9(6):1339-51. PubMed ID: 20172905
[TBL] [Abstract][Full Text] [Related]
16. Regulation of B cell development and B cell signalling by CD22 and its ligands alpha2,6-linked sialic acids.
Ghosh S; Bandulet C; Nitschke L
Int Immunol; 2006 Apr; 18(4):603-11. PubMed ID: 16497829
[TBL] [Abstract][Full Text] [Related]
17. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
Meyer SJ; Linder AT; Brandl C; Nitschke L
Front Immunol; 2018; 9():2820. PubMed ID: 30559744
[TBL] [Abstract][Full Text] [Related]
18. Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2.
Kimura N; Ohmori K; Miyazaki K; Izawa M; Matsuzaki Y; Yasuda Y; Takematsu H; Kozutsumi Y; Moriyama A; Kannagi R
J Biol Chem; 2007 Nov; 282(44):32200-7. PubMed ID: 17728258
[TBL] [Abstract][Full Text] [Related]
19. The ligand interactions of B cell Siglecs are involved in the prevention of autoimmunity to sialylated self-antigens and in the quality control of signaling-competent B cells.
Tsubata T
Int Immunol; 2023 Oct; 35(10):461-473. PubMed ID: 37504378
[TBL] [Abstract][Full Text] [Related]
20. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions.
Nitschke L
Immunol Rev; 2009 Jul; 230(1):128-43. PubMed ID: 19594633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
